Market Access Podcasts | pharmaphorum

Podcasts

Market Access

Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al...

Unpack the impact of Most-Favoured Nations in GLOBE and GUARD pricing models, and TrumpRx, with Alice Valder Curran's clear policy overview.

Market Access

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the go...

Policy experts Alice Valder Curran and Elizabeth Jungman of Hogan Lovells weigh in on Trump's MFN deals, FDA vouchers, and the government shutdown.

Market Access

pharmaphorum podcast Episode 210 - Neal Masia

Smoothing a contract pathway through uncertainty: In convers...

Today's podcast with Entity Risk's Neal Masia includes insights on the 340B Program, PBMs, and risk-based contracts.

Market Access

Frontiers Health limited podcast series, Pilar Fernández Hermida

FH25: Commercialising Health Tech and Deeptech, with Pilar F...

In a new episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with commercial strategy expert Pilar Fernández Hermida.

Market Access

pharmaphorum podcast Episode 141, Alice Valder Curran

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

Alice Valder Curran, a partner at Hogan Lovells, provides an update on what's happening right now with Most Favoured Nations drug pricing.

Market Access

pharmaphorum Episode 200a - Suzanne Aitken, Clinigen

MAPs, EAPs, and patient access: Suzanne Aitken on the challe...

Suzanne Aitken, SVP of managed access at Clinigen, discussing the role of managed access programmes in the current pharmaceutical landscape.

Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al...

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the go...

Smoothing a contract pathway through uncertainty: In convers...

FH25: Commercialising Health Tech and Deeptech, with Pilar F...

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

MAPs, EAPs, and patient access: Suzanne Aitken on the challe...

Basecamp lifts veil on Trillion Gene Atlas genomics push

Using AI-driven synthetic personas to take your insights fur...

Podcasts

Editor's Picks